| Document |
Document Title |
|
WO/2020/165330A1 |
Process for manufacturing ethyleneamine compounds selected from the group of ethyleneamines and hydroxyethylethyleneamines wherein the process comprises two reaction sequences, the first reaction sequence comprising the steps of: - in an...
|
|
WO/2020/162408A1 |
The present invention has the effect of making it possible to produce 1,1,1-trifluoro-2,2-bisarylethane efficiently by a simple procedure by condensing a mixture of fluoral and hydrogen fluoride with an aryl compound under anhydrous cond...
|
|
WO/2020/163839A1 |
The present invention provides ionic liquids (ILs) comprising a carbohydrate anionic moiety and a cationic counter-ion moiety (Q+) and methods for producing and using the same. In one particular embodiment, the carbohydrate anionic moiet...
|
|
WO/2020/163746A1 |
The invention provides for compounds that are HAT activators or inhibitors. The invention further provides a method for treating neurodegenerative diseases, cancer and other malignant conditions, or to increase memory in a subject not su...
|
|
WO/2020/156312A1 |
The present invention relates to a polycyclic derivative modulator, a preparation method therefor and an application thereof. In particular, the present invention relates to a compound represented by general formula (I), a preparation me...
|
|
WO/2020/159135A1 |
The present invention provides: a compound represented by chemical formula 1; an organic electric element comprising a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrod...
|
|
WO/2020/151500A1 |
Disclosed herein are an organic electroluminescent compound, an electroluminescent material and an organic electroluminescent component. The organic electroluminescent compound has the structure of formula (1). The organic electrolumines...
|
|
WO/2020/151499A1 |
Disclosed are a fluorene derivative and an electronic device. Fluorene rigid structure, fluorene derivative film forming ability and thermal stability make the fluorene derivative disclosed herein an excellent candidate for preparing an ...
|
|
WO/2020/154320A1 |
The present disclosure addresses elastomeric adhesives and elastomers that include a modified amine. The modified amine can be the reaction product of an amine with a Michael acceptor. The amine can be represented by H2N-Ar-R1-NH2, where...
|
|
WO/2020/148617A1 |
The present invention disclosed 3-substituted phenylamidine compounds of general formula (I), wherein R1, R2, R3, R4, R4a, R4b, A and E have the same meanings as defined in description. The present invention further discloses methods for...
|
|
WO/2020/149710A1 |
The present invention provides: a compound represented by chemical formula 1; an organic electronic element including a first electrode, a second electrode, and an organic layer formed between the first electrode and the second electrode...
|
|
WO/2020/142545A1 |
Provided are methods of using (1R,5S)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, in free or pharmaceutically acceptable salt form.
|
|
WO/2020/141419A2 |
The present invention relates to novel pharmaceutically acceptable salts of Bempedoic acid, novel intermediates of Bempedoic acid, novel crystalline form of Bempedoic acid and novel processes for the preparation of Bempedoic acid or its ...
|
|
WO/2020/140187A1 |
The present invention belongs to the technical field of organic synthesis, and particularly relates to a method for preparing a high purity dimethyl diallyl ammonium chloride monomer in high yield. The preparation method provided by the ...
|
|
WO/2020/135569A1 |
The present invention relates to the field of medicinal chemistry, and relates to an ethylenediamine compound represented by formula A, pharmaceutically acceptable salts, stereoisomers, tautomers or isomer mixtures thereof, hydrates ther...
|
|
WO/2020/138389A1 |
Provided are: a novel nanoparticle; a contrast agent for magnetic resonance imaging comprising the same; and a zwitterionic ligand compound to be used in the production of the nanoparticle. The contrast agent for MRI according to the pre...
|
|
WO/2020/138837A1 |
The present invention relates to a compound represented by chemical formula 1, an organic optoelectronic device, and a display device.
|
|
WO/2020/133022A1 |
The present invention relates to a Cypyrafluone dimethylamine salt, a preparation method therefor, and use thereof. The present invention specifically relates to a crystal form A of the Cypyrafluone dimethylamine salt, and the X-ray powd...
|
|
WO/2020/130511A1 |
The present specification pertains to: a compound of chemical formula 1; and an organic light-emitting device including same.
|
|
WO/2020/129749A1 |
The present invention provides a method for producing primary amines and secondary amines, the method being characterized by reducing a primary amide or a secondary amide in the presence of a reducing agent and an organic metal halide of...
|
|
WO/2020/132406A1 |
The present invention is directed to a method for making a di(aminoaryl)fluorene compound that includes the steps of: (a) reacting a fluorenone compound according structure (I) with excess aminobenzene according to structure (II) wherein...
|
|
WO/2020/126819A1 |
The present invention relates to a process for preparing compounds of the formula (I), starting from compounds of the formula (II), wherein R1, R2, R3 and R3' are defined according to the invention.
|
|
WO/2020/132196A1 |
Nanoparticle compositions for delivery of nucleic acids to subjects including modified dendrimers comprising cores, one or more of homogeneous or heterogeneous intermediate and terminal layers, and therapeutic or immunogenic nucleic acid...
|
|
WO/2020/130623A1 |
The present specification provides a compound of chemical formula 1 and an organic light-emitting device comprising same.
|
|
WO/2020/119595A1 |
Provided are a phenol salt and application thereof as a catalyst in a hexavalent sulfur-fluoride exchange reaction, said phenol salt comprising cations and anions. The phenol salt is easy to synthesize and can be used as a catalyst for a...
|
|
WO/2020/120637A1 |
The application relates to a compound of formula (I) or a pharmaceutical salt thereof of formula (II), as well as to a process to obtain said compound and a process to obtain said salt. Additionally disclosed is the compound of formula (...
|
|
WO/2020/117654A1 |
The invention is directed at esylate and salicylate salts of cis-N-cyclohexyl-N-ethyl-3-(3-chloro-4-cyclohexylphenyl)prop
-2-enylamine and their pharmaceutical composition. The invention is also directed at the use esylate and salicylate...
|
|
WO/2020/116418A1 |
A compound represented by formula (1). (In the formula, R1-R4 and L1-L4 are as defined in the description; Ar represents a moiety of formula (A) or (B) (wherein R11-R18 and R20-R29 are as defined in the description); and Ar is as defined...
|
|
WO/2020/112357A1 |
Provided herein are compounds of Formula (I), including methods of making the same. The disclosed compounds are succinate dehydrogenase inhibitors and can be useful in, e.g., inhibiting or preventing fungal growth.
|
|
WO/2020/113028A1 |
The present disclosure provides, inter alia, a compound having the structure (1). Also provided are compositions containing a pharmaceutically acceptable carrier and one or more compounds according to the present disclosure. Further prov...
|
|
WO/2020/102936A1 |
A method for preparing a covalent organic framework (COF) material and a method for reversible condensation polymerization/termination polymerization. The COF material prepared by the present method shows high crystallinity, high specifi...
|
|
WO/2020/103006A1 |
A process for preparing a primary amine by reacting an alcohol with ammonia in the present of a metal catalyst comprising metal nanoparticles, wherein the metal nano-particles comprises at least one transition metal in elemental form and...
|
|
WO/2020/106098A1 |
The present specification relates to a compound of chemical formula 1 and an organic light-emitting diode comprising same.
|
|
WO/2019/079607A9 |
The present disclosure relates to a method of preventing or treating a blood disorder (e.g., sickle-cell disease) via administering an EHMT2 inhibitor compound disclosed herein or a pharmaceutical composition thereof to subjects in need ...
|
|
WO/2020/102737A1 |
Disclosed herein are compounds and methods for labeling and quantifying analytes using mass spectrometry.
|
|
WO/2020/098937A1 |
The invention relates to a method for producing an amine by reacting an alcohol, aldehyde and/or ketone with hydrogen and nitrogen-containing compound in the presence of a silver and/or ruthenium promoted cobalt catalyst. The nitrogen-co...
|
|
WO/2020/101413A1 |
The present invention relates to a method for preparing and device for preparing formic acid and, more specifically, to a device for preparing formic acid and method for preparing formic acid efficiently by using same, the device compris...
|
|
WO/2020/093949A1 |
The present invention relates to the field of high-carbon chain alkane diamine preparation, and disclosed thereby are a high-carbon chain alkane diamine, a preparation method therefor and an application thereof. The preparation method fo...
|
|
WO/2020/096001A1 |
A compound represented by formula (1) (wherein R1 to R8, R10 to R19, R30 to R46, Ar, L, and *a are as defined in the description) is useful in providing an organic EL element having improved element performance.
|
|
WO/2020/094847A1 |
The present invention relates to indane derivatives of the formula (I) and mixtures thereof, wherein X is selected from groups of the formulae -A-NH2 or -A-(NAr2), wherein A is a chemical bond or phenylene which is unsubstituted or subst...
|
|
WO/2020/097145A1 |
A polymerizable multifunctional antimicrobial monomer includes a quaternary ammonium cation group, wherein the quaternary ammonium cation ion group is bonded to functional groups and anions having structures chosen from the groups; formu...
|
|
WO/2020/087234A1 |
Disclosed is a method for preparing a benzyl amine compound, i.e., synthesizing a benzyl amine compound by means of an oxidation reaction between a methylbenzene/ethylbenzene compound and arylamine by using an ionic iron(III) complex con...
|
|
WO/2020/090989A1 |
In a production method for a fluorinated aromatic secondary or tertiary amine compound having a fluoroaryl moiety in a molecule, the method comprising reacting a fluorinated aromatic primary amine compound with a chlorinated, brominated,...
|
|
WO/2020/087233A1 |
Disclosed is an application of an ionic iron (III) complex as a catalyst in preparation of a benzylamine compound, that is, an ionic iron (III) complex having a molecular formula of [(RNCHCHNR)CH][FeBr4] (R is tert-butyl) and containing ...
|
|
WO/2020/092693A1 |
An improved method for synthesizing a compound according to formula (I) by reaction of a compound of formula (II) with a sulfinamide according to formula (III). The resultant compound is then reduced and hydrolyzed, and optionally alkyla...
|
|
WO/2020/090294A1 |
Disclosed is an ionic compound which has: at least two cation portions and anion portions, respectively, in a molecule; and at least one linking portion which links two among the cation portions and the anion portions, by using a covalen...
|
|
WO/2020/085396A1 |
A cross-coupling reaction method including: preparation of an aromatic compound (1) that has a leaving group; preparation of a compound (2) capable of a cross-coupling reaction, the compound (2) being selected from aromatic amino compoun...
|
|
WO/2020/085174A1 |
A perovskite nano-crystal thin film comprises a plurality of perovskite nano-crystals which are bonded to each other through ligands to thereby be arranged two-dimensionally or three-dimensionally, wherein each of the perovskite nano-cry...
|
|
WO/2020/086816A1 |
The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.
|
|
WO/2020/087063A1 |
This invention relates to certain compounds or pharmaceutically acceptable salts thereof, and for the use of the compounds to treat cancer. In another aspect, the disclosure relates to a pharmaceutical composition comprising a compound o...
|
